NP / PA
Leysaht, Robert
Leysaht, Robert was paid $286K by Medicaid between Aug 2021 and Dec 2024, across 12 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 62% of everything it billed.
33Billing provider infoLEYSAHT, ROBERT
PEORIA, IL 61615
PEORIA, IL 61615
33aNPI1265064612assigned 02/04/2020
33bProvider typeNurse Practitioner
28Total paid$286K
24GClaims6,247
24DCodes billed12
24AFirst – last monthAug 2021 – Dec 2024
Compared with peers
Next to other Nurse Practitioner providers in Illinois
Rank by total paid#94 of 1,687
Median peer was paid$22K
This provider vs. median13×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2021 | 756 | $28K | |
| 2022 | 1,465 | $64K | |
| 2023 | 1,992 | $84K | |
| 2024incomplete | 2,034 | $110K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 62% | 3,736 | 3,505 | $178K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 827 | 774 | $62K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 4.7% | 343 | 316 | $13K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 2.6% | 213 | 189 | $7K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 2.4% | 278 | 249 | $7K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 2.0% | 375 | 369 | $6K |
| 87428 | 1.8% | 82 | 75 | $5K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 31 | 31 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 71 | 65 | $2K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 39 | 38 | $2K |
| 81025 | <1% | 98 | 87 | $547.08 | |
| 81002 | <1% | 154 | 147 | $395.20 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.